Abstract
Supratentorial primitive neuro-ectodermal tumors (PNET) in adults are very rare. Extraneural metastasis are unusual and the optimal palliative chemotherapy regimen is not established. We present a 26-year-old patient with local recurrence and distant metastasis of supratentorial PNET successfully treated with intensive induction chemotherapy and maintenance temozolomide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255–268
Paulino AC, Melian E (1999) Medulloblastoma and supratentorial primitive neuroectodermal tumors. Cancer 86:142–148
Balafouta MJ, Kouvaris JR, Miliadou AC et al (2002) Primitive neuroectodermal tumour in a 60-year old man: a case report and literature review. Br J Radiol 75:62–65
Kim DG, Lee DY, Paek SH et al (2002) Supratentorial primitive neuroectodermal tumors in adults. J Neurooncol 60:43–52
Soussain C, Patte C, Ostronoff M et al (1995) Small noncleaved cell lymphoma and leukaemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 3:664–674
Brandes AA, Palmisano V, Monfardini S (1999) Medulloblastoma in adults: clinical characteristics and treatment. Cancer Treat Rev 25:3–12
Kayaselcuk F, Zorludemir S, Gumurduhu D et al (2002) PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade. J Neurooncol 57:115–121
Woodburn RT, Azzarelli B, Montebello JF et al (2001) Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/ central nervous system neuroectodermal tumors. J Neurooncol 52:57–62
Ray A, Ho M, MA J et al (2004) A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 10:7613–7620
Peterson K, Walker RW (1995) Medulloblastoma/primitive neuroectodermal tumor in 45 adults. Neurology 45:440–442
Strother D, Ashley D, Kellie SJ et al (2001) Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. J Clin Oncol 10:2696–2704
Pérez-Martínez A, Lassaletta A, González-Vincent M et al (2005) High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol 71:33–38
Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
Hegi ME, Diserens A, Gorlie T et al (2006) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003
Stupp R, Gander M, Leyvraz S et al (2001) Current and future developments in the use of temozolomide for the treatment of brain tumours. Lancet Oncol 2:552–560
Rao DR, Robins HI, Mehta MP (2001) Late recurrence of a primitive neuro-ectodermal tumour. Oncology 61:189—191
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Terheggen, F., Troost, D., Majoie, C.B. et al. Local recurrence and distant metastasis of supratentorial primitive neuro-ectodermal tumor in an adult patient successfully treated with intensive induction chemotherapy and maintenance temozolomide. J Neurooncol 82, 113–116 (2007). https://doi.org/10.1007/s11060-006-9249-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-006-9249-3